COVID-19 update included
The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic

The Europe Oculoplastic Surgery Market would witness market growth of 5.29% CAGR during the forecast period (2019-2025).
The field of oculoplastic surgery takes much of the plastic surgery principle and applies it to ophthalmology on a micro-scale (microsurgery). The overall emphasis is on the reconstructive or cosmetic enhancement of the eyelids, orbit, tear ducts, and lids and brows. Most oculoplastic surgeons also use injectable such as botulism toxin and/or facial fillers to rejuvenate the faces. There are many forms of eyelid lesions, some can be easily examined while others should be biopsied or excised entirely. A decision can be made about whether to diagnose, biopsy, or remove the lesion depending on the appearance in consultation and the patient’s medical history. Chalazion (stye), skin tags, cysts, and nevi (moles) are among the most common benign eyelid lesions.
Oculoplastic surgery is generally performed to enhance the appearance of patients. Factors such as advances in non-invasive techniques due to benefits, including rapid recovery time and the same-day procedure, are expected to boost the market for oculoplastic surgery. Such techniques are known to dramatically reduce the incidence of postoperative complications that are supposed to work out well for overall market growth in the near future. Rapidly increasing disposable income, higher acceptance of various oculoplastic procedures, and willingness to spend on esthetic surgery are other factors that drive market growth. Social media and celebrities have proved to have a strong impact on customers in the medical aesthetics industry. For example, according to multiple studies in the UK, about 55% of facial plastic surgeons indicated that patients in their practice had been motivated by a desire to look better in selfies in 2017, up from 13 percent in 2016.
Based on Procedure, the market is segmented into Eyelid Surgery, Orbital Surgery, Face Lift, Brow Lift & Forehead Lift and Pediatric Oculoplastic surgery. Based on End Use, the market is segmented into Ambulatory surgical centers and Hospitals & clinics. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Zimmer Biomet Holdings, Inc., B. Braun Melsungen AG, Integra LifeSciences Holdings Corporation, Karl Storz SE & Co. KG, Antibe Therapeutics, Inc. (BMT Medizintechnik GmbH), Stanford Health Care, Tekno-Medical Optik-Chirurgie GmbH, Bolton Surgical Ltd., Blink Medical Ltd. (Katena Products, Inc.), and Sklar Corporation.
Scope of the Study
Market Segmentation:
By Procedure

  • Eyelid Surgery
  • Orbital Surgery
  • Face Lift
  • Brow Lift & Forehead Lift
  • Pediatric Oculoplastic surgery


By End Use

  • Ambulatory surgical centers
  • Hospitals & clinics


By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe


Companies Profiled

  • Zimmer Biomet Holdings, Inc.
  • B. Braun Melsungen AG
  • Integra LifeSciences Holdings Corporation
  • Karl Storz SE & Co. KG
  • Antibe Therapeutics, Inc. (BMT Medizintechnik GmbH)
  • Stanford Health Care
  • Tekno-Medical Optik-Chirurgie GmbH
  • Bolton Surgical Ltd.
  • Blink Medical Ltd. (Katena Products, Inc.)
  • Sklar Corporation


Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free